COLESTID Granule for oral suspension Ref.[9879] Active ingredients: Colestipol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Pharmacodynamic properties

Pharmacotherapeutic group: bile acid sequestrants
ATC code: C10AC02

Ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen.

Pharmacokinetic properties

Colestid is not absorbed; its action is limited to the lumen of the gastro-intestinal tract, and it is passed in the faeces. It binds bile acids in the intestinal lumen and causes them to be excreted in the faeces together with the polymer. When the enterohepatic circulation of bile acids is interrupted, cholesterol conversion to bile acids is enhanced and plasma cholesterol levels are thereby lowered.

Preclinical safety data

Both clinical and animal studies with Colestid have provided no evidence of drug related intestinal neospasms. Colestid is not mutagenic in the Ames test.

Reproduction and teratologic studies in animals gave no evidence of drug toxicity in parents or offspring.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.